73. Blepharoplasty


Print   Close Window
Note: Large images and tables on this page may necessitate printing in landscape mode.

Copyright 2007 The McGraw-Hill Companies.  All rights reserved.

Current Otolaryngology  > XIV. Skull Base > Chapter 65. Neoplasms of the Temporal Bone & Skull Base >

Neoplasms of the Temporal Bone & Skull Base: Introduction

The skull base includes the frontal bone, the sphenoid bone, the temporal bone, and the occipital bone. Tumors arising within the skull base are rare and usually cause few symptoms until they grow to a size in which they begin to affect cranial nerves. Occasionally, an asymptomatic tumor may be diagnosed when a middle ear mass is noted during routine otoscopic examination of the ear. Unfortunately, it is all too common for patients to have complaints of imbalance, unilateral pulsatile tinnitus, mild asymmetric hearing loss, vague headache , facial twitching or facial numbness, as well as to have the diagnosis of a skull base tumor delayed because of an incomplete work-up. By far, the majority of skull base tumors are benign and can be successfully managed with surgical resection by an otolaryngologist specialized in neurotology and skull base surgery. A magnetic resonance imaging (MRI) scan of the brain, skull base, or both, with and without gadolinium contrast, is extremely sensitive at diagnosing these rare tumors with little risk to the patient. Table 651 lists the various skull base neoplasms and their imaging characteristics.

Table 651. Radiographic Appearance of Skull Base Neoplasms.


Neoplasm Most Common Site of Origin in Skull Base CT T1-Weighted MRI T2-Weighted MRI Contrast Enhancement
Paraganglioma Jugular foramen and middle ear Bone destruction Intermediate, with flow voids High, with flow voids Strongly
Facial nerve schwannoma Geniculate ganglion Smooth remodeling and dilation of the surrounding bone of the facial canal Intermediate Intermediate Strongly; follows the course of the facial nerve
Geniculate hemangioma Geniculate ganglion Erosion of surrounding bone with bony spicules within tumor Intermediate High Strongly
Leukemia, lymphoma, and plasmacytoma Petrous apex Lytic lesion Low Intermediate Moderately
Langerhans cell histiocytosis Mastoid Irregular bone destruction; may have other skull lesions as well Intermediate High Moderately
Chondrosarcoma Petroclival junction Bone destruction, but can produce calcium matrix in 50% of tumors Intermediate High Moderately or mixed
Chordoma Clivus Bone destruction, but can have bone remnants within it Intermediate, with some areas of low signal representing mucus High Moderately or mixed
Meningioma Posterior face of temporal bone Surrounding hyperostosis and intratumoral calcification Intermediate Intermediate Strongly; characteristic dural tail
Intralabyrinthine schwannoma Within the inner ear Mass within labyrinth; no bone erosion Low Intermediate Strongly
Schwannoma of jugular foramen Jugular foramen and middle ear Soft tissue mass posterior to jugular bulb; mild, smooth bone erosion Low Intermediate Strongly
Rhabdomyosarcoma Anywhere , predominant tumor of children Bone destruction Intermediate High Strongly
Osteosarcoma Anywhere Either lytic osteoblastic or osteolytic; may have concentric rings of calcium Intermediate High Strongly
Fibrosarcoma Anywhere Bone destruction Intermediate High Strongly
Adenoma Middle ear Middle ear soft tissue mass; no bone erosion Low Intermediate Strongly
Endolymphatic sac tumor Posterior face of temporal bone Bone destruction and erosion of otic capsule Mixed, due to localized areas of mucus Mixed Strongly
Carcinoma Middle ear Bone destruction Intermediate Intermediate Strongly
Metastatic disease Petrous apex and internal auditory canal Lytic lesion Intermediate High Strongly

Tumors of the temporal bone and skull base tend to arise in one of three locations: (1) the mastoid or middle ear, (2) the jugular foramen, or (3) the petroclival junction or petrous apex. Tumors of the cerebellopontine angle and Meckel cave are not considered in this chapter (see Chapter 61, Nonacoustic Lesions of the Cerebellopontine Angle). Surgical approaches to these three areas are numerous , and the nomenclature is confusing. To remove a lesion of the middle ear or mastoid, a mastoidectomy through a postauricular incision or a middle ear exploration through the ear canal is usually adequate. Tumors of the jugular foramen require a postauricular incision that extends down into the upper neck. A mastoidectomy is performed along with skeletonization of the facial nerve, the sigmoid sinus, and the jugular bulb. One classic approach to the jugular foramen is the Fisch Type A approach (Figure 651). This involves dissecting the facial nerve out of its bony canal and rerouting it anteriorly. Permanent facial paresis or synkinesis can occur. Closure of the ear canal is also part of the Fisch Type A approach, which leaves the patient with a maximal conductive hearing loss. However, newer approaches are available that may permit adequate exposure of the jugular foramen without requiring facial nerve rerouting and closure of the ear canal. Finally, tumors of the petroclival junction and petrous apex require either a middle fossa-transpetrous approach with removal of the petrous apex bone (Kawase triangle, Figure 652) or a combined subtemporal-retrolabyrinthine approach (Figure 653). The Fisch Type B and C approaches can also be used to access the petroclival junction and can be extended all the way to the nasopharynx. Surgical strategies are chosen by the skull base surgeon based on approaching the tumor with enough exposure to perform a complete and safe resection while minimizing neurologic morbidity.



Paragangliomas

Essentials of Diagnosis

  • Pulsatile tinnitus.
  • Reddish-blue middle ear mass.

General Considerations

Paragangliomas (or glomus tumors) are tumors of paraganglionic tissue, which originally derive from the migration of neural crest cells during fetal development. These tissue rests are distributed predominantly throughout the middle ear, the jugular foramen, the vagus nerve, and the carotid body, but are also found in the upper mediastinum and the retroperitoneum . These cell clusters are innervated by the parasympathetic nervous system and function as chemoreceptors for circulatory regulation.

The most common paraganglioma is the carotid body tumor. A well-known, but rare, paraganglioma is the pheochromocytoma. Within the temporal bone, there are two main types of paraganglioma: glomus tympanicum and glomus jugulare. Glomus tympanicum tumors arise within the middle ear, from paraganglionic cell rests associated with branches of cranial nerves IX and X (the glossopharyngeal and vagus nerves, respectively) that run over the promontory. Together these nerves are called the tympanic plexus, which consists of the Jacobsen nerve (a branch of CN IX) and the Arnold nerve (a branch of CN X). Glomus jugulare tumors arise within the jugular foramen from cell rests associated with cranial nerves IX, X, and XI.

Pathogenesis

Paragangliomas are most common in white populations. They typically occur in the fourth or fifth decades of life, although they can be identified at any age. Paragangliomas are slow-growing tumors, and metastases are extremely rare. They grow by spreading along the paths of least resistance. Within the skull base, they tend to extend through fissures and foramina, vascular channels, and air cell tract lines. Paragangliomas also demonstrate locally aggressive behavior with bone destruction and the invasion of soft tissue. They can extend from the temporal bone down into the upper neck.

Approximately 1% of paragangliomas display functionally significant catecholamine secretion similar to a pheochromocytoma. Pathologically, the chief cell is the cell of origin of the tumor and contains acetylcholine, catecholamines, and serotonin. Classic findings are clusters of chief cells, termed Zellballen, with a rich vascular plexus throughout the entire tumor. Indeed, these tumors are highly vascular and may bleed substantially during surgical excision .

The overall incidence of multiple lesions is about 10% in sporadic tumors. There is a 12% incidence of bilateral glomus jugulare tumors and a 7% incidence of an associated carotid body tumor. Paragangliomas can be based on germline mutations and can be hereditary. Mutations in the mitochondrial complex II genes SDHB, SDHC, and SDHD cause hereditary paragangliomas. In addition, another form of the disease has an autosomal dominant mode of transmission, and the causative genetic defect has been localized to two separate loci: 11q13.1 and 11q22-23. Patients with hereditary disease display a much higher incidence of synchronous paraganglioma, approximately 2535%.

Paragangliomas are also associated with phakomatoses (neurologic diseases with cutaneous manifestations ). These include von Recklinghausen neurofibromatosis, Sturge-Weber syndrome, tuberous sclerosis, and von Hippel-Lindau disease. In addition, they can be associated with multiple endocrine neoplasia (MEN) Type I syndrome.

Classification

There are two main classification schemes for paragangliomas of the temporal bone: Fisch and Glasscock-Jackson.

Fisch Classification

The Fisch classification includes four main categories: (1) Type A (tumors limited to the middle ear), (2) Type B (tumors limited to the tympanomastoid area), (3) Type C (tumors extending into the petrous apex), and (4) Type D (tumors with intracranial extension).

Glasscock-Jackson Classification

The classification scheme of Glasscock and Jackson differentiates between glomus tympanicum and glomus jugulare tumors.

Glomus Tympanicum Neoplasms

For glomus tympanicum neoplasms, this staging system includes (1) Type I (small masses limited to the promontory of the middle ear), (2) Type II (tumors filling the middle ear space), (3) Type III (tumors filling the middle ear and mastoid), and (4) Type IV (tumors extending into the external auditory canal or around the internal carotid artery).

Glomus Jugulare Neoplasms

For glomus jugulare tumors, this staging system includes (1) Type I (small tumors involving the jugular bulb, the middle ear, and the mastoid); (2) Type II (tumors extending under the internal auditory canal); (3) Type III (tumors extending into the petrous apex); and (4) Type IV (tumors extending beyond the petrous apex into the clivus or infratemporal fossa).

Clinical Findings

Symptoms and Signs

The two most common presenting symptoms of a patient with a paraganglioma of the temporal bone are conductive hearing loss and pulsatile tinnitus. Patients may also complain of aural pain, facial nerve weakness, and a neck mass. The patient should be questioned as to symptoms of sympathetic discharge , which may represent a functionally secreting tumor, such as tachycardia, arrhythmias, flushing, or labile hypertension. Moreover, the patient should be queried about any symptoms of dysphagia or hoarseness, which may represent palsy of cranial nerves IX or X.

Physical examination demonstrates a reddish-bluish mass behind the eardrum. An aural polyp may be noted. There are two clinical signs associated with paraganglioma that can be identified during microscopic exam of the tympanic membrane: (1) Brown sign is the cessation of tumor pulsation and tumor blanching with positive pressure using the pneumatic otoscope; and (2) Aquino sign is the blanching of the mass with manual compression of the ipsilateral carotid artery. A complete examination of the cranial nerves is indicated, with particular attention to cranial nerves VII (the facial nerve), VIII (the vestibulocochlear nerve), IX (the glossopharyngeal nerve), X (the vagus nerve), XI (the accessory nerve), and XII (the hypoglossal nerve).

Laboratory Findings

Patients with a suspected paraganglioma can be screened for a catecholamine secretion by collecting a patient's urine for 24 hours and determining the vanillylmandelic acid (VMA) and metanephrine levels. An audiogram will reveal conductive hearing loss if the middle ear space is invaded with tumor. If the inner ear is invaded, a sensorineural hearing loss will be found. Impedance audiometry will reveal a flat tympanogram if a middle ear mass is present and touches the eardrum. Occasionally, vascular pulsations may be noted on the tympanogram.

Imaging Studies

The importance of imaging paraganglioma of the skull base cannot be underestimated (Figure 654). Imaging is critical to delineate the extent of these tumors precisely. The first thing to determine is whether the jugular foramen is involved with the tumor. A glomus tympanicum is limited to the promontory and the mastoid though a glomus jugulare begins in the jugular foramen and extends superiorly into the middle ear and mastoid. In addition, the studies should be reviewed with careful attention to the middle ear, jugular foramen, and carotid bifurcation to look for a synchronous tumor.

Computed Tomography (CT) Scanning

CT scanning is useful to visualize the bony structures of the temporal bone. Of key importance is to evaluate the bone above the jugular bulb, the jugular plate. If the tumor is a glomus jugulare tumor that has extended into the middle ear cavity , this bone will be eroded. In contrast, if the tumor is a glomus tympanicum tumor, the bone surrounding the jugular bulb is usually intact. Inner ear or facial nerve involvement may also be noted. There may be a semicircular canal fistula or the tumor may be in close proximity to the fallopian canal, particularly along the vertical segment. The tumor may extend anterior to the internal auditory canal or along the petrous portion of the internal carotid artery. These findings may affect the planned surgical approach.

MRI Scanning

MRI studies are useful to identify whether there is intracranial extension of the tumor. MRI gives excellent soft tissue contrast resolution and permits delineation of the tumor from the brainstem, the cerebellum, and the cranial nerves. The tumor has intermediate signal intensity on T1-weighted MRI and high intensity on T2-weighted MRI. Both may demonstrate a speckled pattern within the tumor, termed a "salt and pepper" pattern. This pattern is due to flow voids from the large number of intratumoral blood vessels. The tumor enhances strongly with gadolinium contrast.

Magnetic Resonance Angiography and Venography

Magnetic resonance angiography (MRA) can be used to evaluate for compression of the internal carotid artery. Magnetic resonance venography (MRV) is useful to assess collateral circulation within the dural sinuses of the skull, since blood flow within the sigmoid sinus is often blocked by the tumor.

Angiography

Angiography of glomus jugulare tumors is usually done 1 or 2 days before surgical excision. This permits definitive diagnosis of the tumor by visualizing the tumor blush characteristic of such highly vascular tumors. In addition, the feeding vessels can be identified and embolized to reduce blood loss during surgery. The typical feeding vessels for a glomus jugulare tumor are the ascending pharyngeal artery and the stylomastoid branch of the occipital artery. Glomus tympanicum tumors typically do not need to be embolized preoperatively because of their small size and easy accessibility.

Differential Diagnosis

The differential diagnosis of a patient with a middle ear mass includes otitis media, cholesterol granuloma, other types of middle ear neoplasmsincluding middle ear adenoma or carcinomaa vascular anomaly such as a high- riding dehiscent jugular bulb, an aberrant carotid artery, or a persistent stapedial artery. Other temporal bone neoplasms that might involve the middle ear space include meningiomas, schwannomas or neuromas, adenomas, or endolymphatic sac tumors.

Complications

Hearing Loss

Progressive conductive hearing loss usually is the presenting symptom of patients with a temporal bone paraganglioma. This may occur directly if the tumor contacts the ossicular chain or indirectly if the tumor blocks the eustachian tube, producing a serous middle ear effusion. Sensorineural hearing loss is uncommon but can occur if the tumor erodes the dense otic capsule bone and invades the inner ear. Alternately, the tumor may extend intradurally and affect cranial nerve VIII in the cerebellopontine angle and internal auditory canal.

Facial Nerve Palsy

Paragangliomas of the temporal bone may cause facial nerve palsy (21%) by invading the nerve within the temporal bone. Usually, this occurs along the vertical portion of the nerve within the mastoid. Even if nerve function is unaffected, most glomus jugulare tumors grow to wrap around the facial nerve and erode its bony canal in this location. A microsurgical dissection of a dehiscent nerve surrounded by tumor is the norm and can be quite challenging. (A dehiscent nerve is one in which the bony canal surrounding the nerve has been eroded.)

Jugular Foramen Syndrome

If the jugular foramen is involved with the paraganglioma, the insidious onset of neuropathy of the lower cranial nerves (IX, X, and XI) ensues as they are slowly encroached upon by the tumor. Symptoms include dysphagia and aspiration, as the sensation to the pharynx (CN IX) and the larynx (CN X) is diminished. Also, hoarseness may be noted owing to vocal cord paralysis (CN X). It should be noted that rather than an isolated recurrent laryngeal nerve injury that causes vocal cord paralysis (such as with a Pancoast tumor), the jugular foramen syndrome includes a high vagal nerve injury . This is much more severe because the combination of a lack of sensation to the upper larynx and vocal cord paralysis puts these patients at extremely high risk of aspiration. The paralysis of cranial nerve XI can be noted as weakness and atrophy of the sternocleidomastoid and trapezius muscles .

Hypoglossal Nerve Paralysis

The hypoglossal nerve exits the skull base through the hypoglossal foramen in the occipital bone, anteroinferior to the jugular foramen. Large paragangliomas that extend inferiorly may affect the hypoglossal nerve. The patient may complain of worsening articulation, and the physical exam will demonstrate ipsilateral tongue atrophy, muscular fasciculations, and deviation to the affected side with protrusion.

Horner Syndrome

The sympathetic nerves to the head run from the superior cervical ganglion up along the internal carotid artery into the skull base. Paragangliomas that envelop the petrous portion of the internal carotid artery may cause an ipsilateral Horner syndrome with ptosis, miosis, and ipsilateral facial flushing and sweating.

Other Complications

Large paragangliomas can affect other neurologic functions, depending on the tumor extension. Intradural tumors can grow within the cerebellopontine angle, producing cerebellar dysfunction and imbalance, brainstem compression, and even obstructive hydrocephalus. Tumors that grow superiorly or medially can affect other cranial nerves, causing diplopia (CN IV or VI), facial numbness or pain (CN V), or dry eye (the greater superficial petrosal branch of CN VII).

Treatment

Nonsurgical Measures

Observation

Observation with no treatment is reasonable in patients with minimal symptoms, particularly if they are older. Because glomus tumors are slow growing, serial MRI scans can be obtained, reserving surgery or radiation therapy for obvious tumor growth. This approach is less acceptable for younger patients in whom the tumor would be expected to grow substantially during their life span.

Radiation

The role of radiation therapy in the management of paragangliomas is controversial . Radiation is thought to reduce the growth rate of these tumors; however, it does not eliminate viable tumor cells within the mass. Tumors have been known to recur even more than a decade after radiation therapy. Radiation therapy for paragangliomas of the temporal bone can be useful as a treatment for elderly patients with symptomatic tumors or for patients who are unwilling to undergo a surgical resection. Postoperative stereotactic radiation therapy may be used for patients in whom total tumor removal could not be achieved.

Surgical Measures

Microsurgical total tumor removal is the treatment of choice for most patients. Patients with functionally secreting tumors need to be alpha-blocked with phentolamine before and during surgical resection to prevent life- threatening hypertension as the alpha-adrenergic hormones are released with tumor manipulation.

The surgical approach for resection of paragangliomas of the temporal bone depends on the tumor extent. For a glomus tympanicum tumor that is limited to the middle ear cavity, a simple middle ear exploration through the ear canal may be all that is indicated. After raising the tympanic membrane, the tumor can be visualized on the promontory. It may then be cauterized with a bipolar cautery and removed. If the tumor is larger and extends into the mastoid air cells, a tympanomastoidectomy with an extended facial recess approach may be required. This is a standard mastoidectomy via a postauricular incision with sacrifice of the chorda tympani nerve to allow exposure of the middle ear and hypotympanum from the mastoid. A tumor extending medially to the facial nerve (the retrofacial air cells) can be resected after exposing the facial nerve along its vertical segment to prevent injury to it.

For glomus jugulare tumors, a larger surgical approach is required. One very important aspect during the removal of these tumors is delineation and preservation of the facial nerve. Unfortunately, the vertical segment of the facial nerve lies in the middle of the operative field, and the tumor is usually based directly behind it, wrapping around it. A tympanomastoid approach with an extended facial recess and complete skeletonization of the facial nerve to the stylomastoid foramen typically provides adequate exposure. If possible, the preservation of a thin layer of bone surrounding the facial nerve circumferentially is ideal to minimize risk to the facial nerve (the fallopian bridge technique). It is also important to extend the skin incision into the neck and identify the internal carotid artery and internal jugular vein. The sternocleidomastoid and digastric muscles are separated from the mastoid tip so that the great vessels can be followed up to the skull base. These vessels need to be controlled both proximally and distally to the tumor in case a great vessel rupture occurs.

The most important part of the surgery is resection of the jugular bulb. Superiorly, the sigmoid sinus is occluded in the mastoid cavity, inferior to the junction of the transverse sinus and sigmoid sinus because the vein of Labb enters at that location. Occlusion of the vein of Labb may cause venous infarction of the temporal lobe since it is the only vein draining this territory. Inferiorly, the internal jugular vein is divided and ligated in the neck. Next , the jugular bulb (the lateral wall of the sigmoid sinus and the tumor filling the sinus) is dissected from the posterior fossa dura and cranial nerves IX, X, and XI. There is usually substantial bleeding from the entry point of the inferior petrosal sinus to the jugular bulb during this process. It is important to quickly remove this tumor and pack this area with an absorbable knitted fabric (eg, Surgicel) to control the bleeding. After tumor removal, the mastoid cavity is often packed with fat harvested from the abdominal wall and closed in layers .

Large glomus jugulare tumors, which extend anteriorly along the internal carotid artery, typically require a larger infratemporal fossa surgical approach (Fisch Type A, see Figure 651). This approach involves following the facial nerve from the geniculate ganglion to the pes anserinus, lifting it out of the bony canal, and transposing it anteriorly to displace it out of the surgical field. The jugular spine, the bone between the internal jugular vein and the internal carotid artery as they enter the skull base, can then be fully delineated and removed. This permits dissection of the tumor from the internal carotid artery into the petrous apex. If needed, tumor dissection can extend from the jugular foramen all the way to the nasopharynx. If the tumor extends intracranially, this portion of the tumor should be removed after the vascular base of the tumor around the great vessels has been controlled. This reduces potentially massive intracranial hemorrhage. Large tumors require complete exenteration of the middle ear cavity, packing of the eustachian tube, and closure of the external auditory canal to form a blind pouch. If the tumor is extensive , it is possible that some type of soft tissue reconstructive flap may be needed to reconstruct the defect, such as a pedicled temporalis muscle flap.

Prognosis

Paragangliomas have a slow but relentless growth pattern. For most patients, the treatment of choice is a complete microsurgical removal to prevent worsening morbidity from tumor progression. Observation with no treatment can be performed if the patient is elderly and has only minimal symptoms. The use of radiation therapy is limited to elderly patients with symptomatic tumors, hopefully slowing the growth rate of an already slow-growing tumor. The main question, however, is whether this tumor will cause serious morbidity or mortality in the patient's remaining years . In the end, the treatment of paragangliomas needs to be individualized based on the patient, the disease, and the physician .

The most common complications from surgical excision are those related to cranial neuropathy. These include paresis or palsy of the jugular foramen nerves (CN IX, X, and XI) with resultant hoarseness, dysphagia, and aspiration. These complications may be temporary or permanent. In either case, patients can usually regain the ability to eat within the first few weeks after surgery with swallowing therapy. Facial nerve palsy also can occur during tumor removal, although if the facial nerve is anatomically intact at the end of surgery, a good return of function is expected. As with any skull base surgery, meningitis or cerebrospinal fluid (CSF) leak may occur. There can be significant amounts of blood loss during the resection of these tumors because of their highly vascular nature. Preoperative embolization is quite helpful in reducing the amount of blood loss.

Jackson CG, McGrew BM, Forest JA, Netterville JL, Hampf CF, Glasscock ME III. Lateral skull base surgery for glomus tumors: long- term control. Otol Neurotol. 2001;22:377. (Surgical control rates for paragangliomas.) [PMID: 11347643]

Oghalai JS, Leung MK, Jackler RK, McDermott MW. Transjugular craniotomy for the management of jugular foramen tumors with intracranial extension. Otol Neurotol. 2004;25:570; discussion 579. (Newer approaches for jugular foramen tumors.) [PMID: 15241237]

Weber PC, Patel S. Jugulotympanic paragangliomas. Otolaryngol Clin North Am. 2001;34:1231. (A good review.) [PMID: 11728943]

Facial Nerve Schwannomas

Essentials of Diagnosis

  • Facial twitch.
  • Slowly progressive facial palsy.
  • Conductive hearing loss.

General Considerations

Primary tumors of the facial nerve can arise anywhere from the glial-Schwann cell junction in the cerebellopontine angle into the parotid gland. These are very slow-growing tumors and tend to spread longitudinally along the course of the facial nerve within the temporal bone (the fallopian canal). These tumors are histologically similar to vestibular schwannomas (acoustic neuromas) except for the fact that they rise along a different cranial nerve.

The diagnosis of a facial nerve schwannoma is frequently delayed because of the slow rate of tumor growth and symptom development. Patients with Bell's palsy in whom facial nerve function was not of acute onset should be evaluated for a facial nerve schwannoma. Also, patients with facial palsy that does not begin to demonstrate the return of function within 69 months of onset should be evaluated for a facial nerve schwannoma.

Clinical Findings

Symptoms and Signs

The clinical findings depend on the precise location of the tumor. For facial nerve schwannomas that begin in the cerebellopontine angle or internal auditory canal, the most common clinical findings are sensorineural hearing loss, tinnitus, vestibular dysfunction, and balance. These findings are precisely the same symptomatology as those of a patient with an acoustic neuroma. Patients with facial nerve schwannomas within the fallopian canal present with facial nerve palsy and twitch. They can also present with conductive hearing loss if the mass impinges upon the middle ear ossicles. Extratemporal facial nerve schwannomas typically present as an asymptomatic firm mass in the parotid gland.

For all locations, a common patient history is a slow onset of facial nerve palsy over 36 months, which has not improved even after several years. Usually, facial spasm is noted before the onset of facial paralysis. Occasionally, a patient with a facial nerve schwannoma presents with facial palsy of rapid onset (over 12 days). These patients are diagnosed with idiopathic Bell's palsy and treated with corticosteroids. Although steroids may reduce tumor edema and initially lead to an improvement in facial nerve function, the facial nerve palsy will return over the next few weeks as the effects wear off.

Imaging Studies

CT Scanning and MRI

CT scanning is quite useful in identifying the extent of bony erosion and dilatation of the fallopian canal. In addition, it delineates whether the tumor mass impinges upon the ossicles. An MRI scan with gadolinium contrast is superior for defining the extent of the tumor within the cerebellopontine angle and the parotid gland (Figure 655). The tumor has an intermediate signal intensity on both T1- and T2-weighted MRI.

It can be difficult to differentiate between an acoustic neuroma and a facial nerve schwannoma within the internal auditory canal. However, facial nerve schwannomas typically follow the course of the facial nerve. They extend into the temporal bone, involving the geniculate ganglion and horizontal portion of the facial nerve within the middle ear. In contrast, acoustic neuromas stop at the fundus, which is the distal portion of the internal auditory canal (IAC).

Audiometry

Audiometry often demonstrates conductive hearing loss. The ipsilateral acoustic reflex may have elevated thresholds or show abnormal decay functions.

Differential Diagnosis

The differential diagnosis of a facial nerve schwannoma in the cerebellopontine angle and IAC includes vestibular schwannoma, meningioma, and epidermoid cyst. If the tumor involves the geniculate ganglion or the intratemporal facial nerve, the differential diagnosis includes cholesteatoma, paraganglioma, and geniculate hemangioma. If a parotid mass is palpable, all types of benign and malignant parotid tumors are within the differential diagnosis. For any patient with unilateral peripheral facial palsy, both idiopathic Bell's palsy and Ramsey-Hunt syndrome should be included in the differential diagnoses.

Treatment

Nonsurgical Measures

These tumors are extremely slow growing and typically cause slowly progressive facial nerve palsy. Observation is the treatment of choice until the facial nerve palsy is substantial (House-Brackmann Grade 4 or greater) or symptoms of brainstem compression occur.

Surgical Measures

Because surgical excision requires resection of the involved segment of the nerve and grafting of the facial nerve, a significant postoperative facial nerve deficit is to be expected. After nerve grafting or hypoglossal-facial nerve transfer has been performed, the best facial nerve function that can be expected is a House-Brackmann Grade 3. The surgical approach depends on the precise location of the tumor. If the tumor is limited to the IAC and cerebellopontine angle, a retrosigmoidal or middle cranial fossa approach can be used to try to preserve hearing. Typically, the middle fossa approach allows better exposure of the facial nerve as it lies on the superior aspect of the nerves within the IAC. If hearing has already been lost, a translabyrinthine approach allows the best exposure of the complete length of the facial nerve. If the facial nerve schwannoma is limited to the middle ear or mastoid, a postauricular tympanomastoidectomy approach can be used. Although this approach does not allow exposure of the IAC, complete exposure from the geniculate ganglion to the parotid gland can be obtained.

Tumor removal involves transecting the facial nerve on either side of the schwannoma. If only a small segment of the nerve is involved, the nerve may be mobilized out of its canal and repaired primarily. Otherwise, a nerve graft either from the great auricular nerve or the sural nerve can be grafted between the segments. If the proximal portion of the facial nerve is involved at the brainstem, nerve grafting may be impossible and a hypoglossal-facial nerve transposition can be performed.

Prognosis

After the initial diagnosis, close follow-up is warranted with a serial MRI, CT scan, or both to determine whether there is evidence of tumor growth. As long as symptoms are stable, these tumors can be followed. If surgical excision is required, routine eye care is needed until facial nerve function returns. This may require the use of artificial tears and Lacri-Lube (a nighttime eye lubricant), a protective eye shield, or the placement of a gold weight in the upper eyelid. Patients may also have conductive or sensorineural hearing loss that needs to be managed accordingly .

Fenton JE, Chin RY, Tonkin JP, Fagan PA. Transtemporal facial nerve schwannoma without facial nerve paralysis. J Laryngol Otol. 2001;115:559. (Surgical excision of facial nerve tumors.) [PMID: 11485588]

Liu R, Fagan P. Facial nerve schwannoma: surgical excision versus conservative management. Ann Otol Rhinol Laryngol. 2001;110: 1025. (The management of facial nerve tumors.) [PMID: 11713912]

Geniculate Hemangiomas

General Considerations

Hemangiomas are benign tumors of blood vessels. They are the most common tumor of infancy and typically resolve spontaneously by the time the child is 5 to 6 years old. Within the temporal bone, hemangiomas have a predilection for the geniculate ganglion of the facial nerve. These are different from typical hemangiomas in that they are not associated with pediatric patients. They are usually identified in middle-aged adults.

Pathogenesis

Geniculate hemangiomas arise directly from the geniculate ganglion. The bony floor of the middle cranial fossa is dehiscent over the tumor in nearly all cases. The tumor can extend superiorly into the middle cranial fossa but typically remains extradural. It can also track distally along the distal portion of the facial nerve but does not extend beyond the horizontal segment. Geniculate hemangiomas usually do not extend proximally into the IAC; however, hemangiomas can arise primarily within the internal auditory canal, which similarly do not extend to the geniculate ganglion.

Clinical Findings

Symptoms and Signs

The most common presenting symptom of geniculate hemangiomas is slowly progressive facial paralysis. Rarely, a patient may present with a rapid onset of facial paralysis. Although a patient may have a geniculate hemangioma without facial paralysis, it would be unusual to diagnose this lesion without this symptom. Facial paralysis may simulate Bell's palsy (idiopathic facial paralysis), with improvement in facial function with steroid treatment; however, the facial palsy recurs as the effect of the steroids wears off.

Facial twitch and spasm can be identified in patients with tumors compressing the facial nerve and have been reported in patients with geniculate hemangiomas. Hearing loss is typically conductive owing to impingement of the tumor on the ossicular mass in the middle ear. These tumors usually do not erode the otic capsule and do not affect the IAC; therefore, sensorineural hearing loss is unusual. Patients may complain of symptoms related to compression of the greater superficial nerve, including either epiphora or dry eye. On physical exam, the patient may present with a red mass behind the eardrum and the Weber and Rinne tuning fork tests suggest a conductive hearing loss in that ear.

Imaging Studies

CT scans demonstrate a soft tissue density in the area of the geniculate ganglion with bony dehiscence and erosion of the floor of the middle cranial fossa around the geniculate ganglion (Figure 656). Classically, there may be intratumoral calcifications or bone spicules within the tumor, which are diagnostic for a hemangioma. However, the absence of calcium within the tumor does not rule out a hemangioma. MRI is useful in delineating the intracranial extent of the tumor. It enhances intensely with gadolinium contrast. On T1-weighted images without contrast, the tumor has the same density as brain tissue; on T2-weighted images, the tumor is bright.

Differential Diagnosis

The differential diagnosis of a geniculate lesion includes facial nerve schwannomas, meningioma, metastases, cholesteatomas, cholesterol granulomas, and mucoceles.

Treatment

Nonsurgical Measures

These lesions demonstrate slow but progressive growth. Observation can be considered in an older or debilitated patient in whom surgical risks are felt to be too great.

Surgical Measures

Surgical excision is the treatment of choice for most patients with these tumors since they clearly grow and cause worsening symptoms. Although they are next to the facial nerve, they usually do not infiltrate the nerve nor do they extend intradurally. Surgery often permits complete tumor resection with minimal impact on the facial nerve function. However, large tumors can affect final facial nerve outcomes . The best surgical strategy is via a middle cranial fossa approach, with care to identify the interface between the tumor and the dura during the initial elevation of the dura off the floor of the middle cranial fossa. The tumor can usually be delicately microdissected from the geniculate ganglion with facial nerve preservation.

Prognosis

Surgical excision is curative. There have been no recurrence rates reported.

Isaacson B, Piccirillo E, Agarwal M, Rohit, Khrais T, Sanna M. Management of temporal bone hemangiomas. Ann Otol Rhinol Laryngol. 2004;113:431. (Facial nerve results after surgical tumor resection.) [PMID: 15224824]

Telian SA, McKeever PE, Arts HA. Hemangiomas of the geniculate ganglion. Otol Neurotol. 2005;26:796. (Hemangiomas infiltrate the facial nerve.) [PMID: 16015187]

Malignant Hematologic Disorders

Leukemia

Leukemia is the production of an abnormally high number of white blood cells that become deposited in various organs and sites within the body. The temporal bone is one site that occasionally becomes infiltrated, typically within the marrow of the petrous apex. Involvement of the middle ear cleft and mastoid can also occur; however, it is unusual for leukemic infiltrates to involve the inner ear or the facial nerve. Patients with leukemia are immunosuppressed and are highly prone to developing acute otitis media. Hemorrhage into the middle ear can also occur. Up to 32% of patients with leukemia have otologic symptoms, usually due to eustachian tube dysfunction with resultant middle ear effusion and conductive hearing loss. Obstruction of the eustachian tube can occur along its length or at its opening to the nasopharynx at the adenoid bed. A solid tumor known as a granulocytic sarcoma or chloroma is occasionally noted with myelogenous leukemia. This is a localized concentration of neoplastic granulocytic cells that begins within the marrow of the petrous apex.

CT scanning demonstrates a lytic lesion, and MRI shows the mass to have low-signal intensity on T1-weighted images and intermediate intensity on T2-weighted images. It enhances moderately with contrast. The treatment for leukemic infiltrates, granulocytic sarcoma, or both is based on systemic chemotherapy; there is no need for surgical treatment of this disease. Occasionally, a myringotomy is useful to drain fluid out of the middle ear cleft and for culture of the middle ear effusion if infection is suspected. Very rarely, a mastoidectomy is required if coalescent mastoiditis has developed or for biopsy purposes.

Lymphoma

Lymphoma can infiltrate the marrow spaces of the temporal bone, typically within the petrous apex. Like patients with leukemia, these patients can have eustachian tube dysfunction or hemorrhage into the middle ear with resultant middle ear effusion and conductive hearing loss. It is unusual to see destruction of the inner ear or facial nerve in this group of patients. The treatment of the disease is systemic chemotherapy and radiation therapy.

Plasmacytoma

The head and neck are the most common sites of an extramedullary plasmacytoma (ie, plasmacytoma arising anywhere outside of the bone marrow). Lesions usually involve the Waldeyer ring, which includes the tonsils, adenoids, and lymphoid tissue along the base of tongue. Very rarely, extramedullary plasmacytomas may involve the temporal bone, usually within the middle ear and mastoid air cells. Patients with this lesion present with eustachian tube dysfunction, middle ear effusion, and conductive hearing loss. Occasionally, a middle ear mass is identified. Surgery may be required to perform a biopsy, but once the diagnosis has been made, it is important to search for disseminated disease suggestive of multiple myeloma (found in 31% of patients with extramedullary plasmacytoma). This includes staging CT scans and a bone marrow biopsy.

The treatment for a solitary extramedullary plasmacytoma is based on radiation therapy alone. Debulking surgery is not generally recommended; however, limited resection with preservation of the facial nerve and inner ear can be performed during the biopsy. It is not recommended to perform a radical resection because this is not thought to improve outcomes. The 5-year survival rate is 69% for patients with isolated extramedullary plasmacytomas of the head and neck. If disseminated plasmacytoma or multiple myeloma is identified, chemotherapy is usually recommended in combination with radiation therapy.

Chiang SK, Canalis RF, Ishiyama A, Eversole LR, Becker DP. Plasmacytoma of the temporal bone. Am J Otolaryngol. 1998;19: 267. (Review article.) [PMID: 9692637]

Lewis WB, Patel U, Roberts JK, Palis J, Teot L. Angiocentric T-cell lymphoma of the temporal bone. Otolaryngol Head Neck Surg. 2002;126:85. (Case report.) [PMID: 11821775]

Langerhans Cell Histiocytosis

Essentials of Diagnosis

  • Chronic otitis media, otorrhea, and an aural polyp in a child.

General Considerations

Langerhans cell histiocytosis is a proliferation of cells that arise from the bone marrow and are found circulating within the blood and lymph nodes and at junctional areas between the body and the outside environment (eg, along epithelial and endothelial surfaces). The role of normal histiocyte function is to present antigens to both T cells and B cells to initiate an immune response.

Other terms for Langerhans cell histiocytosis include histiocytosis X, eosinophilic granuloma, Hand-Sch



Current Diagnosis and Treatment in Otolaryngology
Current Diagnosis and Treatment in Otolaryngology
ISBN: 0735623031
EAN: 2147483647
Year: 2004
Pages: 76

flylib.com © 2008-2017.
If you may any questions please contact us: flylib@qtcs.net